• Patients receive 8 cycles of neoadjuvant FOLFIRINOX chemotherapy followed by surgery without adjuvant treatment (arm A), or 3 cycles of neoadjuvant gemcitabine with hypofractionated radiotherapy (36 Gy in 15 fractions) during the second cycle, followed by surgery and 4 cycles of adjuvant gemcitabine (arm B). The primary endpoint is OS by intention-to-treat. (nih.gov)
  • They were all treated with Intensity-modulated radiation therapy (IMRT) combined with systemic treatments, including radiotherapy alone (RT alone), neoadjuvant chemotherapy followed by radiotherapy (NACT+RT), CCRT, NACT+CCRT, NACT followed by radiotherapy and adjuvant chemotherapy (NACT+RT+AC), CCRT+AC and NACT+CCRT+AC. (oncotarget.com)
  • Platinum-based concurrent chemoradiotherapy represents the gold standard in the treatment of locally advanced nasopharyngeal carcinoma (NPC) [ 1 , 2 ] in the era of 2D radiotherapy. (oncotarget.com)
  • The other study, PORTEC (Post-Operative Radiation Therapy in Endometrial Carcinoma), compared the standard of care with adjuvant chemotherapy during and after radiotherapy for patients with high-risk endometrial cancer. (medpagetoday.com)
  • A total of 686 women were accrued, randomly assigned to either chemoradiotherapy or radiotherapy only. (medpagetoday.com)
  • Treatments were assigned based on clinical TNM stage and patient health: stage I patients received radiotherapy alone, stage II patients received radiotherapy alone or platinum-based concurrent radiochemotherapy, and advanced-stage patients (stage III through stage IV) were given concurrent chemoradiotherapy and neoadjuvant or adjuvant chemotherapy. (cancertherapyadvisor.com)
  • Twenty-five patients received radiotherapy alone, and all of the other patients (106) were administered a combination of radiotherapy and chemotherapy. (cancertherapyadvisor.com)
  • Eight patients who had whipple operation received radiotherapy (RT) with concurrent CT. (yyu.edu.tr)
  • As adjuvant treatment dose, 45 Cy (1,8 Gy/fx/day) radiotherapy was administered to pancreas and regional lymph nodes. (yyu.edu.tr)
  • Surgery was performed for all patients in the early stage, and adjuvant radiotherapy or/and chemotherapy was applied to 52.6% (n = 40) of nonmetastatic patients. (medipol.edu.tr)
  • Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients? (bezmialem.edu.tr)
  • Standard treatment involves surgery followed by adjuvant chemo/radiotherapy as appropriate. (aku.edu)
  • Patients who have received prior neo-adjuvant, adjuvant chemotherapy, radiotherapy, or chemo-radiotherapy with curative intent for non-metastatic disease must have experienced a treatment free interval of at least 6 months from enrollment since the last chemotherapy, radiotherapy, or chemo-radiotherapy cycle. (genentech-clinicaltrials.com)
  • Regarding treatment, more SRC patients received surgery, radiotherapy and chemotherapy than non-SRC patients. (biomedcentral.com)
  • In August 2021, the U.S. FDA approved nivolumab for the adjuvant treatment of people with urothelial carcinoma (UC) who are at high risk of recurrence after undergoing radical resection. (wikipedia.org)
  • however, she received adjuvant chemoradiotherapy and had no recurrence after 4 years. (bmj.com)
  • 2,3] Local and/or distant recurrence is common following resection, highlighting the importance of adjuvant therapy. (cancernetwork.com)
  • There exists a significant risk of recurrence after neoadjuvant chemoradiotherapy (NCRT) and surgery among the three-fourth of patients with carcinoma esophagus who do not achieve complete pathological remission (PCR). (thieme-connect.com)
  • Local and distant recurrence rates after non-total mesorectal excision (TME) surgery alone are as high as 40%-60% [ 2 ], thus warranting adjuvant therapy to improve local/regional control. (biomedcentral.com)
  • After providing written informed consent, these adjuvant chemoradiotherapy (NCRT) is being used in patients will undergo sphincter-preserving therapies patients with LARC (T3-T4 or N0-N1), with the pur- including either NCRT with surgery, or NCT with sur- pose of reducing the local recurrence rates and increas- gery or surgery only. (sagepub.com)
  • People receiving operation for gastric cancer without adjuvant chemotherapy are at risk for disease recurrence. (springeropen.com)
  • Data from a recent randomized trial enrolling only patients with II-IIIB gastric cancer revealed a 36 % recurrence rate in 5 years for patients without adjuvant chemotherapy after D2 dissection (Noh et al. (springeropen.com)
  • Adjusted Cox regression analyses were used to compare overall and recurrence-free survival according to adjuvant treatment. (ljmu.ac.uk)
  • CONCLUSION: Adjuvant therapy may improve overall survival and recurrence-free survival after margin-positive resection. (ljmu.ac.uk)
  • Nasopharyngeal carcinoma (NPC) patients with N2-3 diseases are prone to develop distant metastasis even treated with standard concurrent chemoradiotherapy (CCRT). (oncotarget.com)
  • In the absence of similar research, we endeavored to investigate the prognostic usefulness of posttreatment neutrophil-to-lymphocyte ratio (NLR) in patients treated with definitive concurrent chemoradiotherapy (CCRT) for locally advanced pancreatic adenocarcinoma (LAPAC). (hindawi.com)
  • however, chemotherapy (CT), concurrent chemoradiotherapy (CCRT), and induction CT followed by CCRT are the most often utilized alternatives [ 6 ]. (hindawi.com)
  • To compare patient survival outcomes between completion hysterectomy and conventional surveillance in locally advanced adenocarcinoma of the cervix after concurrent chemoradiotherapy (CCRT). (koreamed.org)
  • 4. Yang J, Shen K, Wang J, Yang J, Cao D. Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma. (koreamed.org)
  • Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy. (koreamed.org)
  • INTERVENTION: All of the patients received 50 Gy of radiation with concurrent continuous infusion of fluorouracil for 5 weeks. (elsevierpure.com)
  • The primary therapy for early stage cervical cancer is surgery and that for locally advanced disease is concurrent chemoradiotherapy. (koreamed.org)
  • The addition of adjuvant chemotherapy seemed to provide benefits to patients with N3 stage NPC and the current study may indicate the need for further randomized investigation. (oncotarget.com)
  • The results showed an increase in failure-free survival, 75.5% in the chemoradiotherapy arm, compared with 68.6% in the patients treated with radiation only, but the 5-year survival rate did not improve with the addition of adjuvant chemotherapy. (medpagetoday.com)
  • Nivolumab is indicated for the adjuvant treatment of people with melanoma with involvement of lymph nodes or in people with metastatic disease who have undergone complete resection. (wikipedia.org)
  • In May 2021, the U.S. FDA approved nivolumab for people with completely resected esophageal or gastroesophageal junction (GEJ) cancer with residual pathologic disease who have received neoadjuvant chemoradiotherapy. (wikipedia.org)
  • CheckMate -67T is a Phase 3 randomized, open-label trial evaluating subcutaneous administration of Opdivo co-formulated with Halozyme's proprietary recombinant human hyaluronidase, rHuPH20, or subcutaneous nivolumab (nivolumab and hyaluronidase) compared to intravenous (IV) Opdivo , in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC) who have received prior systemic therapy. (businesswire.com)
  • 1 ] Therefore, CheckMate 577 (CM577), a global, randomized, double-blind, placebo-controlled phase 3 trial, has explored the role of an immune checkpoint inhibitor (ICPI), Nivolumab as adjuvant therapy in patients with esophageal or gastroesophageal junction (GEJ) cancer who did not achieve a PCR. (thieme-connect.com)
  • In clinical trials of previously treated patients with advanced esophageal or GEJ tumors with squamous-cell carcinoma (SCC) or adenocarcinoma histology, the overall survival (OS) in the nivolumab arm was higher than those who received either chemotherapy or placebo. (thieme-connect.com)
  • Among patients with completely resected stage II or III esophageal or GEJ cancer (R0 resection) who had received NCRT and did not achieve a PCR, an impressive doubling of disease-free survival (DFS) was seen in the nivolumab arm in comparison with the placebo arm. (thieme-connect.com)
  • 8 ] In CM577, at 2 years median follow-up, the median DFS was 29 months on the adjuvant Nivolumab arm for patients with SCC and R0 resection. (thieme-connect.com)
  • This DFS on the CM577, despite preoperative chemoradiation, R0 resection, and adjuvant nivolumab, is grossly inferior to the DFS on the surgery alone arm of the NEOCRETEC 5010 study. (thieme-connect.com)
  • Adjuvant nivolumab in subset analysis did not show benefit on PDL1 expression by TPS. (thieme-connect.com)
  • 5) benefitted from adjuvant nivolumab (29.4 vs. 10.2 months). (thieme-connect.com)
  • In a single-arm, single-center phase 2 trial, patients with HER2-negative metastatic esophagogastric adenocarcinoma received 1L chemotherapy FOLFOX6 combined with nivolumab and regorafenib. (esdo.eu)
  • Although surgical resection remains the cornerstone of treatment, local and distant failure rates are high after complete resection, and debate continues as to the appropriate adjuvant therapy. (cancernetwork.com)
  • Historically, after surgical resection adjuvant therapy would be delivered if high-risk features were discovered upon pathologic examination of the surgical specimen. (biomedcentral.com)
  • In UK practice, surgical resection margin status is often used to classify patients for receiving adjuvant treatment. (ljmu.ac.uk)
  • Concerning micro-RNAs, the overexpression of miR-21 was associated with a shorter disease-free survival in patients who received adjuvant gemcitabine after surgical resection [24], and miR-21 overexpression predicts resistance to 5-fluorouracil [25]. (ipa2014.org)
  • Plan for gross total surgical resection via trans oral surgery with curative intent and at least unilateral neck dissection OR chemoradiotherapy. (mayo.edu)
  • Population-based survival and costs of pancreas adenocarcinoma patients receiving adjuvant chemoradiation and chemotherapy following pancreaticoduodenectomy are poorly understood. (hopkinsacg.org)
  • This retrospective cohort study used linked administrative and pathological datasets to identify all patients diagnosed with pancreas adenocarcinoma and undergoing pancreaticoduodenectomy in Ontario between April 2004 and March 2014, who received postoperative chemoradiation or chemotherapy. (hopkinsacg.org)
  • Patients receiving chemoradiation were more likely to have positive margins: 47.7% compared with 19.2% in chemotherapy. (hopkinsacg.org)
  • Others, however, view locoregional failure as a significant contributor to morbidity and mortality, thereby justifying the use of adjuvant chemoradiation. (cancernetwork.com)
  • Patients in each group received 0, 2, 4, or 6 cycles of modified FOLFOX6 after chemoradiation and before total mesorectal excision. (elsevierpure.com)
  • This is called chemoradiation or chemoradiotherapy. (cancercouncil.com.au)
  • If you have chemoradiation, you will usually receive chemotherapy a few hours before some radiation therapy appointments. (cancercouncil.com.au)
  • more patients receive systemic treatment, fewer patients undergo futile surgery, and R0 resection rates are higher, thereby possibly improving overall survival (OS). (nih.gov)
  • Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin. (ljmu.ac.uk)
  • The aim of this study was to assess the survival benefit of adjuvant therapy in patients with positive (R1) resection margins. (ljmu.ac.uk)
  • Among them, new adjuvant chemoradiotherapy followed by selective radical resection of rectal cancer is one of the generally recognized methods for the treatment of advanced rectal cancer [ 13 - 15 ]. (hindawi.com)
  • CONCLUSIONS: Adding modified FOLFOX6 after chemoradiotherapy and before total mesorectal excision increases compliance with systemic chemotherapy and disease-free survival in patients with locally advanced rectal cancer. (elsevierpure.com)
  • Fan, Xin-Juan 2023-05-22 00:00:00 Background Neoadjuvant chemoradiotherapy (NCRT ) and total mesorectal excision are standard treatment regimen for patients with locally advanced rectal cancer (LARC). (sagepub.com)
  • BMC Cancer (2023) 23:467 Page 2 of 7 Keywords Anorectal function, Locally advanced rectal cancer, Neoadjuvant chemoradiotherapy, Total mesorectal excision, Sphincter preservation treatments Introduction and Wexner continence score or LARS score after differ - Background and rationale ent treatment regimens would be investigated. (sagepub.com)
  • 75 years were included in a subgroup analysis in which the benefit of adjuvant chemotherapy on relapse-free survival and overall survival were demonstrated for patients with stage III disease. (springeropen.com)
  • Before 2000, there was no large-scaled randomized phase III trial to evaluate the benefit of adjuvant chemotherapy on the survival of patients with gastric cancer after operation. (springeropen.com)
  • A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. (helsedirektoratet.no)
  • However, an important role exists for the use of chemotherapy and/or radiation therapy in an adjuvant or neoadjuvant setting, and in the treatment of patients with unresectable disease. (medscape.com)
  • To help other treatments - Radiation therapy is often used before other treatments (neoadjuvant) to shrink the tumour or after other treatments (adjuvant) to kill any remaining cancer cells. (cancercouncil.com.au)
  • In this paper, we introduce a case of advanced Parkinson's disease with 10 years of medical control in which the patient received subthalamic nuclei (STN) DBS therapy through frameless surgery. (jmedscindmc.com)
  • BACKGROUND: The role of adjuvant therapy in patients with oesophagogastric adenocarcinoma treated by neoadjuvant chemotherapy is contentious. (ljmu.ac.uk)
  • There must be sufficient tumor biopsy tissue available for evaluation prior to the start of any anti-cancer treatment (if receiving neoadjuvant therapy). (who.int)
  • The aim of this retrospective study is to investigate therapeutic patterns and survival outcomes for a cohort of older NPC patients receiving radiation therapy (RT) with or without chemotherapy (CT). (jcancer.org)
  • Should adults aged ≥19 years who are or will be immunodeficient or immunosuppressed because of disease or therapy be recommended to receive two doses of recombinant zoster vaccine for the prevention of herpes zoster and related complications? (cdc.gov)
  • Iwase H, Indo T, Shimada M, Tsuzuki T, Nakarai K, Kaida S, Doi R, Okeya M and Kato E: Esophageal cancer with colonic metastasis successfully treated by chemoradiotherapy followed by chemotherapy with S-1 and cisplatin. (spandidos-publications.com)
  • Patients with metastatic esophageal cancer who declined chemotherapy but received palliative care had a numerically higher, but not statistically significant, difference in overall survival. (ascopost.com)
  • Individual Participant Data (IPD) Network Meta-Analysis (NWA) of Neoadjuvant Chemo- or Chemoradiotherapy in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma confirms overall survival benefit for both strategies over surgery alone. (esdo.eu)
  • The MANATEC-02 collaborative group conducted an IPD-NWA to evaluate whether neoadjuvant chemotherapy and chemoradiotherapy have a differential effect on survival for esophageal or GEJ carcinoma and, in particular, across histology, location, and sex. (esdo.eu)
  • Neoadjuvant chemotherapy and chemoradiotherapy were consistently better than S alone across histology, but with some variation in the magnitude of treatment effect by sex for CRS (larger OS benefit for females) and tumor location for CS (larger OS benefit for GEJ). (esdo.eu)
  • This pattern seems most pronounced with adjuvant chemoradiotherapy in non-responders to neoadjuvant chemotherapy. (ljmu.ac.uk)
  • Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. (helsedirektoratet.no)
  • Adjuvant chemoradiotherapy (CRT) is the standard of care for gastric cancer patients in the USA. (bezmialem.edu.tr)
  • The aim of this study is to compare the outcomes in pN3 gastric cancer patients following two adjuvant treatment modalities: chemotherapy (CT) and CRT after D2 lymph node dissection. (bezmialem.edu.tr)
  • Adjuvant chemotherapy prolongs relapse-free and overall survival for patients with stage III gastric cancer in a real-world situation. (springeropen.com)
  • Information on adjuvant chemotherapy in gastric cancer is largely derived from meta-analyses. (springeropen.com)
  • Although some meta-analyses suggested a positive effect of adjuvant chemotherapy on survival of patients with gastric cancer (Hejna et al. (springeropen.com)
  • The mean number of total chemotherapy cycles differed among the 4 groups (p = 0.002), because one third of patients in the group assigned to no preoperative FOLFOX did not receive any adjuvant chemotherapy. (elsevierpure.com)
  • In 2004, a randomized trial from Germany was published establishing a regimen of preoperative chemoradiotherapy and surgery followed by additional cycles of chemotherapy alone as the standard of care for clinical stages T3 or T4, or for node-positive rectal cancer [ 3 ]. (biomedcentral.com)
  • After 12 months of follow-up, the patient who received the frameless surgery showed a significant improvement in clinical motor functions compared with his preoperative scores. (jmedscindmc.com)
  • BACKGROUND: Adding modified FOLFOX6 (folinic acid, fluorouracil, and oxaliplatin) after chemoradiotherapy and lengthening the chemoradiotherapy-to-surgery interval is associated with an increase in the proportion of rectal cancer patients with a pathological complete response. (elsevierpure.com)
  • Until now, a series of novel adjuvant chemoradiotherapy have been recommended for patients with TNM stage rectal cancer [ 16 ]. (hindawi.com)
  • It can be prescribed for locally advanced or metastatic form of the condition that experience disease progression during or following platinum-containing chemotherapy or have progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. (wikipedia.org)
  • According to the systemic treatment modalities delivered, we classified all 547 patients into non-adjuvant chemotherapy (non-AC) group (341 patients) and adjuvant chemotherapy (AC) group (206 patients). (oncotarget.com)
  • Kaplan-Meier and Cox proportional hazards regression survival analyses were used to determine associations between adjuvant treatment approach and survival, while stratifying by margin status. (hopkinsacg.org)
  • Further therapeutic advances and prospective trials are needed to better define the optimal role of adjuvant and neoadjuvant treatment in patients with resectable pancreatic cancer. (cancernetwork.com)
  • 4,5] Despite the use of neoadjuvant and adjuvant therapies, little progress has been made in the last three decades, and the search for more efficacious treatment continues. (cancernetwork.com)
  • 7] Additionally, the inclusion of both CRT and adjuvant CT after surgery evaluated two treatment variables, making it difficult to discern the true effect of either treatment alone. (cancernetwork.com)
  • In the CRT arm, there were issues of compliance, with 32% of patients assigned to CRT receiving inappropriate radiation and 25% of patients failing to initiate treatment within 10 weeks post surgery, the protocol-specified time limit. (cancernetwork.com)
  • Patient and tumor characteristics and adjuvant and metastatis treatment outcomes were analyzed retrospectively. (medipol.edu.tr)
  • Patients currently receiving treatment with Opdivo monotherapy for HCC, or their healthcare providers, who have questions about access and reimbursement support are encouraged to contact BMS Access Support at 1-800-861-0048 or www.bmsaccesssupport.com. (bms.com)
  • Of these, 112 patients (46·3 per cent) received adjuvant chemoradiotherapy, 46 (19·0 per cent) were treated with adjuvant chemotherapy and 84 (34·7 per cent) had no adjuvant treatment. (ljmu.ac.uk)
  • P = 0·004) were observed for adjuvant chemoradiotherapy versus no adjuvant treatment. (ljmu.ac.uk)
  • Receiving any other investigational agent which would be considered as a treatment for the primary neoplasm. (mayo.edu)
  • NOTE: If there is a history or prior malignancy, they must not be receiving other specific treatment for their cancer. (mayo.edu)
  • Receiving any medications or substances which in the opinion of the investigators would interfere with treatment. (mayo.edu)
  • The PREOPANC-2 trial investigates whether neoadjuvant FOLFIRINOX improves OS compared with neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine in resectable and borderline resectable pancreatic cancer patients. (nih.gov)
  • Our retrospective research included a sum of 126 LAPAC patients who received CCRT. (hindawi.com)
  • Patients received completion hysterectomy or surveillance after CCRT. (koreamed.org)
  • Many oncologists advocate for adjuvant chemotherapy alone, given that high rates of systemic metastases are the primary cause of patient mortality. (cancernetwork.com)
  • In this article, we review the data surrounding the use of chemotherapy (CT) and chemoradiotherapy (CRT) in patients with resectable pancreatic cancer. (cancernetwork.com)
  • Whereas there were worse neuropathy outcomes at 12 months with mFOLFOX6, the toxicities with chemoradiotherapy "tip the scale" in favor of chemotherapy. (medscape.com)
  • To further explore this topic, we retrospectively analyzed the impact of adjuvant chemotherapy on the clinical outcomes of 77 stage II and 117 stage III patients diagnosed between January 2008 and December 2012. (springeropen.com)
  • In the CheckMate -743 trial, this dual immunotherapy combination demonstrated a clinically meaningful improvement in survival over the standard of care, with 41% of patients who received Opdivo plus Yervoy still alive at two years, compared to only 27% with chemotherapy," said Abderrahim Oukessou, M.D., vice president, thoracic cancers development lead, Bristol Myers Squibb. (pharmiweb.com)
  • Two recent randomized trials have suggested benefit of neoadjuvant chemoradiotherapy over upfront surgery, both including single-agent chemotherapy regimens. (nih.gov)
  • This NWA included 26 published randomized controlled trials, that completed accrual before the end of 2015, comparing at least two of the following strategies: upfront surgery (S), chemotherapy followed by surgery (CS), and chemoradiotherapy followed by surgery (CRS). (esdo.eu)
  • It may depend on whether the long-term neuropathy associated with chemoradiotherapy may be more relevant for some, such as musicians, while the early toxicities with mFOLFOX6 may be unsupportable for people looking after young families. (medscape.com)
  • Aim: Pancreatic cancer is a highly lethal malignancy and in locally advanced disease, chemotherapy (CT) or chemoradiotherapy (CRT) are implemented. (yyu.edu.tr)
  • With a median follow-up time of 53.8 months, adjuvant chemotherapy significantly decreased the risk of distant metastasis (HR 0.413, 95% CI 0.194-0.881, p = 0.022) as well as significantly increased the OS (HR 0.398, 95% CI 0.187-0.848, p = 0.017) in patients with N3 disease. (oncotarget.com)
  • The prospective analysis included 131 patients with NPC who had received no prior anticancer medications and did not have metastasis at diagnosis. (cancertherapyadvisor.com)
  • Improving survival in women with high-risk, early-stage (stages I-II) endometrial cancer has been the goal of research exploring various modalities such as radiation plus chemotherapy, vaginal cuff brachytherapy plus chemotherapy, and adjuvant chemotherapy. (medpagetoday.com)
  • The overall survival rate was 91% for PXRT versus 88% for VCB/C. While no differences were seen between vaginal or distant failure, pelvic or para-aortic nodal recurrences were more common in the patients receiving VCB/C (25 versus 12). (medpagetoday.com)
  • 5. Platt SL, Patel A, Humphrey PJ, Al-Booz H, Bailey J. Completion surgery after chemoradiotherapy for cervical cancer - is there a role? (koreamed.org)
  • Patients were recommended to receive adjuvant chemotherapy after surgery to complete a total of 8 cycles of modified FOLFOX6. (elsevierpure.com)
  • There are limited data of randomized clinical trials with adjuvant chemotherapy to support evidence-based decision-making [ 6 - 8 ]. (oncotarget.com)
  • 2002 ). Fortunately, in the last decade, randomized, placebo-controlled, phase III clinical trials have proven the survival advantage conferred by adjuvant chemotherapy after D2 lymph node dissection (Noh et al. (springeropen.com)
  • Higher overall survival from adjuvant chemotherapy in stage II patients with node involvement did not reach the level of statistical significance ( P = 0.102). (springeropen.com)
  • Our trial clearly demonstrates that adjuvant pelvic radiation should remain the standard of care for high-risk, early-stage endometrial cancer patients," the lead author of the study, Marcus Randall, MD, of the University of Kentucky College of Medicine in Lexington, said in an ASTRO news release. (medpagetoday.com)
  • The aim of this retrospective study was to investigate the general characteristics and survival of our patients receiving CRT. (yyu.edu.tr)
  • A total of 630 patients received chemotherapy during the study period and were included. (ecancer.org)
  • A secondary analysis including only patients who received ≥1 cycle of FOLFOX still showed differences in survival between study groups (p = 0.03). (elsevierpure.com)
  • Among the treatments for improving survival in women with high-risk and early-stage endometrial cancer are radiation plus chemotherapy, vaginal cuff brachytherapy plus chemotherapy, and adjuvant chemotherapy. (medpagetoday.com)
  • 67 breast cancer patients receiving NACT between March 2012 and March 2020 were identified. (aku.edu)
  • Characterizing the epidemiology of head and neck cancers is challenging and has received limited attention in the medical literature. (cancernetwork.com)
  • Despite this overall burden, the epidemiology of head and neck cancers receives limited attention in the medical literature. (cancernetwork.com)